In cerebral small vessel disease (SVD), ischemic lesions are
|
|
- Chloe Jennings
- 5 years ago
- Views:
Transcription
1 Cerebral Small Vessel Disease and Risk of Death, Ischemic Stroke, and Cardiac Complications in Patients With Atherosclerotic Disease The Second Manifestations of ARTerial disease-magnetic Resonance (SMART-MR) Study Mandy M.A. Conijn, MD, PhD; Raoul P. Kloppenborg, MD; Ale Algra, MD, PhD; Willem P.Th.M. Mali, MD, PhD; L. Jaap Kappelle, MD, PhD; Koen L. Vincken, PhD; Yolanda van der Graaf, MD, PhD; Mirjam I. Geerlings, PhD; for the SMART Study Group Background and Purpose Cerebral small vessel disease may be related to vascular and nonvascular pathology. We assessed whether lacunar infarcts and white matter lesions on MRI increased the risk of vascular and nonvascular death and future vascular events in patients with atherosclerotic disease. Methods Brain MRI was performed in 1309 patients with atherosclerotic disease from the Second Manifestations of ARTerial disease-magnetic Resonance (SMART-MR) study. Infarcts were scored visually and volumetric assessment of white matter lesion was performed. Patients were followed for a median of 4.5 years (range, 0.2 to 7.1 years) for death, ischemic stroke, and ischemic cardiac complications. Results Cox regression models showed that presence of lacunar infarcts (n 229) increased the risk of vascular (hazard ratio, 2.6; 95% CI, 1.4 to 4.9) and nonvascular death (hazard ratio, 2.7; 95% CI, 1.3 to 5.3), adjusted for age, sex, vascular risk factors, nonlacunar infarcts, and white matter lesion. These risks were similar for patients with silent lacunar infarcts. White matter lesion volume (relative to total intracranial volume) increased the risk of vascular death (hazard ratio per milliliter increase, 1.03; 95% CI, 1.01 to 1.05) and white matter lesions in the upper quintile compared with lower quintiles increased risk of ischemic stroke (hazard ratio, 2.6; 95% CI, 1.3 to 4.9). Conclusions Cerebral small vessel disease, with or without a history of cerebrovascular disease, is associated with increased risk of death and ischemic stroke in patients with atherosclerotic disease. (Stroke. 2011;42: ) Key Words: lacunar infarcts outcome small vessel disease white matter disease In cerebral small vessel disease (SVD), ischemic lesions are located in the supplying areas of the small perforating arteries in the basal ganglia or in the deep white matter of the brain. Both macrovascular disease such as atherosclerosis and hypertension and microvascular disease such as endothelial dysfunction and leakage of the blood brain barrier have been associated with SVD. 1 4 On MRI, markers of cerebral SVD are visible as white matter lesions (WML) and lacunar infarcts (). They increase the risk of stroke, cognitive decline, dementia, and death, both in the general population and in patients with stroke. 5 8 Patients with atherosclerosis have a high risk of vascular events. It is not known whether the presence of or WML imposes an additional risk of death or vascular events on top of pre-existent vascular disease. The only study that investigated WML in patients with established atherosclerotic disease showed that WML increased the risk of ischemic stroke and myocardial infarction. 9 There are no studies concerning adverse outcomes in patients with atherosclerotic disease in relation to lacunar infarcts. In population-based studies, cerebral SVD has also been associated with retinopathy and nephropathy. 10,11 It is assumed that underlying generalized SVD is responsible for this association, which is supported by the observation that similar pathological changes (eg, hyaline arteriolosclerosis) are found in kidneys of patients with hypertensive nephrop- Received June 30, 2010; final revision received May 18, 2011; accepted June 2, Joanna M. Wardlaw, MD, was the Guest Editor for this paper. From the Department of Radiology (M.M.A.C., W.P.T.M.M.), University Medical Center Utrecht (UMCU), Utrecht, the Netherlands; the Julius Center for Health Sciences and Primary Care (M.M.A.C., R.P.K., A.A., Y.v.d.G., M.I.G.), UMCU, Utrecht, the Netherlands; the Department of Neurology (R.P.K.), Academic Medical Center, Amsterdam, the Netherlands; the Department of Neurology and Rudolf Magnus Institute of Neuroscience (A.A.), UMCU, Utrecht, the Netherlands; and the Image Sciences Institute (K.L.V.), UMCU, Utrecht, the Netherlands. The online-only Data Supplement is available at Correspondence to Mirjam I. Geerlings, PhD, UMC Utrecht, Julius Center, Str , PO Box 85500, 3508 GA Utrecht, the Netherlands. m.geerlings@umcutrecht.nl 2011 American Heart Association, Inc. Stroke is available at DOI: /STROKEAHA
2 3106 Stroke November 2011 athy and in brains of patients with cerebral SVD. 12,13 Nephropathy itself is associated with increased all-cause mortality, 14 and because WMLs are associated with nonvascular pathology such as pneumonia, 15 it can be hypothesized that patients with or WML are at risk for both vascular and nonvascular events. We investigated whether WML and increased the risk of vascular and nonvascular death and the risk of future vascular events in a cohort of patients with atherosclerotic disease. Methods Second Manifestations of ARTerial Disease-Magnetic Resonance Study Data were used from the Second Manifestations of ARTerial disease-magnetic Resonance (SMART-MR) study, a prospective cohort study on brain changes on MRI in patients with symptomatic atherosclerotic disease. 16 Between May 2001 and December 2005, all patients newly referred to the University Medical Center Utrecht with manifest coronary artery disease, cerebrovascular disease, peripheral arterial disease, or an abdominal aortic aneurysm and without MR contraindications were invited to participate. Coronary artery disease was defined as myocardial infarction, coronary artery bypass graft surgery, or percutaneous transluminal coronary angioplasty in the past or at inclusion. Cerebrovascular disease was defined as a transient ischemic attack or stroke at inclusion diagnosed by a neurologist or self-reported stroke in the past. Peripheral arterial disease was defined as surgery or angioplasty of the arteries supplying the lower extremities in the history or intermittent claudication or rest pain at inclusion. Aneurysm of the abdominal aorta (AAA) was defined as present AAA (distal aortic diameter 3 cm) or previous AAA surgery. All patients underwent MRI of the brain, a physical examination, ultrasonography of the carotid arteries, and blood and urine sampling. Risk factors, medical history, and functioning were assessed with questionnaires. The SMART-MR study was approved by the ethics committee of our institution and written informed consent was obtained from all patients. MRI Protocol The MR investigations were performed on an 1.5-Tesla whole-body system (Gyroscan ACS-NT; Philips Medical Systems, Best, the Netherlands). The protocol consisted of transversal T1-weighted (TR/TE 235/2 ms), T2-weighted (TR/TE 2200/11 ms and 2200/ 100 ms), fluid-attenuating inverse recovery (TR/TE/inversion time 6000/100/2000 ms) and inversion recovery (TR/TE/inversion time 2900/22/410 ms) sequences. Field of view was mm, matrix size , slice thickness 4.0 mm, no gap, and 38 slices. Brain Segmentation We used the T1-weighted, inversion recovery, and fluid-attenuating inverse recovery sequence for the probabilistic segmentation technique. 17,18 It distinguishes cortical gray matter, white matter, cerebrospinal fluid, and lesions. The results of the segmentation analysis were visually checked for the presence of infarcts and adapted if necessary to make a distinction between WML and infarct volumes. Total brain volume was calculated by summing the volumes of gray and white matter and, if present, the volumes of WML and infarcts. All volumes cranial to the foramen magnum were included. Total intracranial volume was calculated by summing total brain volume and cerebrospinal fluid volume. WML volumes were divided by intracranial volume and multiplied by the study population mean intracranial volume. Infarcts Infarcts were visually rated by an investigator and neuroradiologist blinded to clinical characteristics and re-evaluated in a consensus meeting. Infarcts were defined as focal hyperintensities on T2- weighted images of 3 mm in diameter. Hyperintensities in the white matter had to be hypointense on T1-weighted and fluidattenuating inverse recovery images to distinguish them from WML. Dilated perivascular spaces were distinguished from infarcts on the basis of their location, form, and absence of gliosis. Infarcts were categorized as lacunar (sized 3 to 15 mm in diameter in plane and located in the subcortical white matter, thalamus, or basal ganglia) and nonlacunar (cortical infarcts, large subcortical infarcts, infratentorial infarcts). Covariates Glucose and lipid levels were determined in an overnight fasting venous blood sample. Height and weight were measured to calculate body mass index. Blood pressure was measured twice with a sphygmomanometer and the average was calculated. Hypertension was defined as mean systolic blood pressure 160 mm Hg or mean diastolic blood pressure 95 mm Hg or antihypertensive drug use. Diabetes mellitus was defined as a history of diabetes mellitus, glucose 7.0 mmol/l, or oral antidiabetic drugs or insulin use. Hyperlipidemia was defined as total cholesterol 5.0 mmol/l, low-density lipoprotein cholesterol 3.2 mmol/l, or lipid-lowering drug use. Smoking (pack-years) and alcohol intake (never, former, current) were assessed with questionnaires. Study Sample Of the 1309 patients participating in the SMART-MR study, MR data were irretrievable for 19 patients; 14 had no fluid-attenuating inverse recovery sequence; and 44 patients had no brain volume data due to motion or artifacts. Four patients were lost to follow-up. Consequently, the analyses were performed in 1228 patients. Follow-Up Patients received a questionnaire every 6 months to provide information on hospitalization and outpatient clinic visits. If a cardiovascular event was reported, original source documents were retrieved and reviewed to determine the occurrence of cardiovascular disease. All possible events were audited independently by 3 physicians of the End Point Committee. Patients were followed until death or refusal of further participation. The outcomes used in this study were death, ischemic stroke, and ischemic cardiac complications (see Supplemental Table I for definitions; Data Analysis Patients were followed from date of MRI scan until death, loss to follow-up, or end of follow-up (March 2009), whichever came first. Cox regression analysis was used to estimate associations of the presence of with death, ischemic stroke, or ischemic cardiac complications adjusted for age and sex (Model 1); hypertension, diabetes mellitus, body mass index, smoking, alcohol consumption, and hyperlipidemia (Model 2); and presence of non- on MRI or a history of clinically evident cerebrovascular disease (Model 3). History of clinically evident cerebrovascular disease was defined as self-reported stroke or carotid operation in the clinical history or inclusion in the study with stroke or transient ischemic attack as a diagnosis. Analyses were repeated with silent, defined as on MRI but no history of clinically evident cerebrovascular disease. The same models were used to analyze associations of WML with death, ischemic stroke, and cardiac complications. WML was analyzed as a continuous variable per milliliter relative to intracranial volume and as a dichotomized variable (upper quintile [ 4.2 ml] versus the 4 lower quintiles). The same adjustments were made as in the models for, except for Model 3 in which we adjusted for all infarcts or history of clinically evident cerebrovascular disease. Finally, all analyses were additionally adjusted for diagnosis of atherosclerotic disease at inclusion. Furthermore, interaction terms were tested between and diagnosis at inclusion and between WML and diagnosis at inclusion for all outcomes. SPSS 15.0 (Chicago, IL) was used to analyze the data.
3 Conijn et al Cerebral Small Vessel Disease and Future Events 3107 Table 1. Baseline Characteristics n 1228 Men, % 977 (79.6) Age, y* Hypertension, % 632 (51.5) Diabetes mellitus, % 247 (20.1) Smoking, pack-years 28.9 (0 50.4) Body mass index, kg/m 2 * Alcohol consumption Never, % 194 (15.8) Former, % 111 (9.0) Current, % 915 (74.5) Hyperlipidemia, % 954 (77.7) History of clinically evident cerebrovascular disease, % 282 (23.0) Lacunar infarcts, % 229 (18.6) White matter lesion volume relative to total intracranial 1.58 ( ) volume, ml SD indicates standard deviation. *Means with SDs. Median (10th to 90th percentile). Table 2. Relationship Between Lacunar Infarcts and White Matter Lesions and Death No. of Deaths No. per 1000 Person-Years Results Table 1 shows the baseline characteristics of the study sample. Two hundred twenty-nine patients had one or more. Of these, 127 had a history of clinically evident cerebrovascular disease and 102 had no such history. Among the 999 without, 155 had a history of clinically evident cerebrovascular disease and 844 had no such history. Patients in the upper quintile of WML had a median WML volume of 7.7 ml (10th to 90th percentile 4.6 to 22.5 ml). In total, 106 patients died during a median follow-up of 5.3 years (range, 0.2 to 8.1 years). Mortality One or more s increased the risk of all-cause death in model 1 (hazard ratio [HR], 3.0; 95% CI, 2.0 to 4.4), which remained significant in Models 2 and 3 (Table 2). In patients without a history of clinically evident cerebrovascular disease (n 946), also increased the risk of all-cause death after adjusting for age and sex (HR, 3.6; 95% CI, 2.2 to 6.0, P 0.001) and also after additional adjustment for vascular risk factors, non-, and WML (HR, 3.2; 95% CI, 1.8 to 5.5; P 0.001). WML significantly increased the risk of all-cause death in Models 1, 2, and 3 (per milliliter increase as well as upper quintile of WML; Table 2). Fifty-seven patients (53.8%) had a vascular cause of death (sudden death n 18, stroke n 10, congestive heart failure n 7, myocardial infarction n 4, AAA rupture n 4, other vascular causes n 14). Presence of significantly increased risk of vascular death in Models 1, 2, and 3 (Table 2). Silent also significantly increased risk of vascular death (HR, 4.1; 95% CI, 1.9 to 8.7; P 0.001) adjusted for all covariates. WML significantly increased the risk of vascular death in Models 1, 2, and 3 (per milliliter increase as well as upper quintile of WML; Table 2). significantly increased risk of nonvascular death after adjusting for all covariates (Table 2) as did silent after Hazard Ratio (95% CI) Model 1 Model 2 Model 3 All-cause death Absent (n 999) reference 1 1 Present (n 229) ( ) P ( ) P ( ) P WML per milliliter (n 1228) ( ) P ( ) P ( ) P Upper quintile (n 246) ( ) P ( ) P ( ) P Vascular death Absent (n 999) Present (n 229) ( ) P ( ) P ( ) P WML per milliliter (n 1228) ( ) P ( ) P ( ) P Upper quintile (n 246) ( ) P ( ) P ( ) P Nonvascular death Absent (n 999) Present (n 229) ( ) P ( ) P ( ) P WML per milliliter (n 1228) ( ) P ( ) P ( ) P Upper quintile (n 246) ( ) P ( ) P ( ) P indicates lacunar infarcts; WML, white matter lesions; CI, confidence interval. Model 1, adjusted for age and sex. Model 2, model 1 hypertension, diabetes mellitus, body mass index, smoking, alcohol consumption. and hyperlipidemia. Model 3:, Model 2 nonlacunar infarcts on MRI or clinical history of stroke and WML; WML, Model 2 all other infarcts on MRI or history of clinically evident cerebrovascular disease.
4 3108 Stroke November 2011 Table 3. Relationship Between Lacunar Infarcts and White Matter Lesions and Ischemic Stroke and Ischemic Cardiac Complication No. of Vascular Events No. per 1000 Person-Years Hazard Ratio (95% CI) Model 1 Model 2 Model 3 Ischemic stroke Absent (n 999) reference 1 1 Present (n 229) ( ) P ( ) P ( ) P WML per milliliter (n 1228) ( ) P ( ) P ( ) P Upper quintile (n 246) ( ) P ( ) P ( ) P Ischemic cardiac complication Absent (n 999) Present (n 229) ( ) P ( ) P ( ) P WML per milliliter (n 1228) ( ) P ( ) P ( ) P Upper quintile (n 246) ( ) P ( ) P ( ) P indicates lacunar infarcts; WML, white matter lesions; CI, confidence interval. Model 1, adjusted for age and sex. Model 2, Model 1 hypertension, diabetes mellitus, body mass index, smoking, alcohol consumption, and hyperlipidemia. Model 3:, Model 2 nonlacunar infarcts on MRI or clinical history of stroke and WML; WML, Model 2 all other infarcts on MRI or history of clinically evident cerebrovascular disease. adjusting for all covariates (HR, 2.6; 95% CI, 1.1 to 6.0; P 0.028). WMLs were not significantly associated with nonvascular death (Table 2). Ischemic Stroke Symptomatic as well as silent significantly increased risk of ischemic stroke; however, in Model 3, this risk decreased and was no longer statistically significant. Similarly, WML per milliliter was no longer significant after adjustment for infarcts on MRI or history of stroke, although severe WML remained significant in Model 3 (Table 3). Ischemic Cardiac Complications Symptomatic as well as silent and WML were not significantly associated with risk of ischemic cardiac complications (Table 3). In all analyses, additional adjustment for atherosclerotic disease at inclusion resulted in similar effect estimates and did not change the significance levels (data not shown). All interactions tested were nonsignificant, except for the interaction between with AAA for the outcome ischemic cardiac complications (HR, 4.90; 95% CI, 1.20 to 20.00). However, the number of patients with AAA was very small and this could also be a chance finding. Twenty-two patients were included with symptomatic without clinically apparent concomitant coronary artery disease, peripheral artery disease, AAA, or carotid artery stenosis of 50%. Exclusion of these patients did not change the results (data not shown). Likewise, exclusion of 37 patients with non- without other clinically apparent manifestations of atherosclerotic disease did not change the results (data not shown). Discussion We found that presence of on MRI, whether symptomatic or asymptomatic, increased the risk of vascular and nonvascular death in patients with symptomatic atherosclerotic disease. also increased the risk of future ischemic stroke, but this was explained by concomitant infarcts on MRI and a history of clinically evident cerebrovascular disease. Severe WML load increased the risk of vascular death and ischemic stroke irrespective of concomitant cerebrovascular disease. Our finding that WML and led to an increased risk of all-cause death is consistent with studies in different study populations. 5,8,15 More interesting was that s were not only associated with vascular death, but also with nonvascular death. In our cohort, the majority of nonvascular deaths were the result of fatal malignancy (72.5%). As previously shown for nephropathy, 14 these results show that the presence of is associated with increased morbidity and mortality not exclusively resulting from vascular events. In this respect, could be a marker of overall increased vulnerability to adverse outcomes, indicating the clinical relevance of in patients with manifestations of atherosclerotic disease outside the brain. Furthermore, our results indicate that silent s, which are generally not treated, may actually be important for the patients prognosis. Previous studies showed that treatment with statins can improve vascular function in patients with symptomatic and WML. 19 However, further research is needed to investigate whether this treatment also improves clinical outcomes of patients with apparently asymptomatic and WML. For, the increased risk of ischemic stroke was explained by other infarcts on MRI and a history of clinically evident cerebrovascular disease. Patients with severe WML load did have an increased risk of ischemic stroke after adjusting for other infarcts and a history of stroke. This is consistent with 2 other studies in older populations that found a relation between WML and risk of ischemic stroke, although those were not adjusted for other infarcts. 9,20 Although it is thought that and WML are both caused by small vessel changes in the brain, the differential associations
5 Conijn et al Cerebral Small Vessel Disease and Future Events 3109 with nonvascular death suggest that the prognosis may be different and we tentatively hypothesize that and WML may actually be 2 separate forms of SVD. Further studies within 1 study population and in population-based studies are needed to investigate this hypothesis. Strengths of our study are the large number of patients included, the virtually complete follow-up, the rigorous assessment of clinical outcomes, the analyses within patients without a history of clinically evident cerebrovascular disease, the automated brain segmentation, and the adjustment of confounders. Also, the large sample size enabled us to also analyze silent. Previously published studies investigated silent infarcts in general and did not look specifically at. 7 Furthermore, our study is the first to specifically investigate nonvascular death. A limitation is that it is difficult to verify if silent infarcts are really clinically asymptomatic. We tried to minimize misclassification by excluding patients who had a transient ischemic attack or stroke at inclusion or reported a transient ischemic attack or stroke in the past. Furthermore, infratentorial infarcts were scored as nonlacunar, although 14 patients had infratentorial infarcts 15 mm without having any other lacunar infarcts supratentorial. This could have led to some underestimation of the results for. Furthermore, not all s show cavitation, and noncavitating s may resemble WML. 21 This could also be a source of underestimation of. Finally, we investigated multiple outcomes and adjusted for many potential confounders with a relatively small number of events and the results should be interpreted with caution. In conclusion, s and WMLs on MRI are risk factors for adverse outcomes in patients with atherosclerotic diseases. Further research is needed to investigate whether the presence of s or WMLs have added value in models to predict prognosis in patients with atherosclerotic disease. Appendix Members of the SMART Study Group of UMC Utrecht: A. Algra, MD, PhD, Julius Center and Rudolf Magnus Institute for Neurosciences, Department of Neurology; P.A. Doevendans, MD, PhD, Department of Cardiology; Y. van der Graaf, MD, PhD, D.E. Grobbee, MD, PhD, G.E.H.M. Rutten, MD, PhD, Julius Center for Health Sciences and Primary Care; L.J. Kappelle, MD, PhD, Department of Neurology; W.P.Th.M. Mali, MD, PhD, Department of Radiology; F.L. Moll, MD, PhD, Department of Vascular Surgery; and F.L.J. Visseren, MD, PhD, Department of Vascular Medicine. Sources of Funding The research is supported by the Dutch Ministry of Welfare and Health and the Netherlands Organization for Scientific Research (project no ). They had no involvement in study design; collection, analysis, or interpretation of data; writing of the report; or in the decision to submit paper for publication. Disclosures Y.v.d.G. received support from the Dutch Ministry of Welfare and Health. M.I.G. received support from the Netherlands Organization for Scientific Research. References 1. Bots ML, van Swieten JC, Breteler MM, de Jong PT, van Gijn J, Hofman A, et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet. 1993;341: Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 1994;44: Wardlaw JM, Doubal F, Armitage P, Chappell F, Carpenter T, Munoz MS, et al. Lacunar stroke is associated with diffuse blood brain barrier dysfunction. Ann Neurol. 2009;65: Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke. 2003;34: de Jong G, Kessels F, Lodder J. Two types of lacunar infarcts: further arguments from a study on prognosis. Stroke. 2002;33: Debette S, Beiser A, DeCarli C, Au R, Himali JJ, Kelly-Hayes M, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke. 2010;41: Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6: Ikram MA, Vernooij MW, Vrooman HA, Hofman A, Breteler MM. Brain tissue volumes and small vessel disease in relation to the risk of mortality. Neurobiol Aging. 2010;30: Gerdes VE, Kwa VI, ten Cate H, Brandjes DP, Buller HR, Stam J. Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease. Atherosclerosis. 2006;186: Ikram MA, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, Breteler MM. Kidney function is related to cerebral small vessel disease. Stroke. 2008;39: Kwa VI, van der Sande JJ, Stam J, Tijmes N, Vrooland JL. Retinal arterial changes correlate with cerebral small-vessel disease. Neurology. 2002; 59: Gamble CN. The pathogenesis of hyaline arteriolosclerosis. Am J Pathol. 1986;122: van Swieten JC, van den Hout JH, van Ketel BA, Hijdra A, Wokke JH, van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain. 1991;114: Rifkin DE, Katz R, Chonchol M, Fried LF, Cao J, de Boer I, et al. Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol Dial Transplant. 2010;25: Briley DP, Haroon S, Sergent SM, Thomas S. Does leukoaraiosis predict morbidity and mortality? Neurology. 2000;54: Geerlings MI, Appelman AP, Vincken KL, Algra A, Witkamp TD, Mali WP, et al. Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART-MR study. Atherosclerosis. 2010;210: Anbeek P, Vincken KL, van Osch MJ, Bisschops RH, van der Grond J. Automatic segmentation of different-sized white matter lesions by voxel probability estimation. Med Image Anal. 2004;8: Anbeek P, Vincken KL, van Osch MJ, Bisschops RH, van der Grond J. Probabilistic segmentation of white matter lesions in MR imaging. 19. Sterzer P, Meintzschel F, Rosler A, Lanfermann H, Steinmetz H, Sitzer M. Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease. Stroke. 2001;32: Vermeer SE, Hollander M, Van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003;34: Potter GM, Doubal FN, Jackson CA, Chappell FM, Sudlow CL, Dennis MS, et al. Counting cavitating lacunes underestimates the burden of lacunar infarction. Stroke. 2010;41:
Brain tissue and white matter lesion volume analysis in diabetes mellitus type 2
Brain tissue and white matter lesion volume analysis in diabetes mellitus type 2 C. Jongen J. van der Grond L.J. Kappelle G.J. Biessels M.A. Viergever J.P.W. Pluim On behalf of the Utrecht Diabetic Encephalopathy
More informationAssociation of White Matter Lesions and Lacunar Infarcts With Executive Functioning
American Journal of Epidemiology Advance Access published September 25, 2009 American Journal of Epidemiology ª The Author 2009. Published by the Johns Hopkins Bloomberg School of Public Health. All rights
More informationORIGINAL ARTICLE. Carotid Atherosclerosis and Progression of Brain Atrophy: The SMART-MR Study
ORIGINAL ARTICLE Carotid Atherosclerosis and Progression of Brain Atrophy: The SMART-MR Study Majon Muller, MD, PhD, 1,2 Yolanda van der Graaf, MD, PhD, 2 Ale Algra, MD, PhD, 2,3 Jeroen Hendrikse, MD,
More informationDepartment of Radiology, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands 3
SAGE-Hindawi Access to Research Aging Research Volume 2011, Article ID 280630, 8 pages doi:10.4061/2011/280630 Research Article Progression of White Matter Lesion Volume and Health-Related Quality of Life
More informationCompleteness of the circle of Willis and risk of ischemic stroke in patients without cerebrovascular disease
Neuroradiology (2015) 57:1247 1251 DOI 10.1007/s00234-015-1589-2 DIAGNOSTIC NEURORADIOLOGY Completeness of the circle of Willis and risk of ischemic stroke in patients without cerebrovascular disease Tom
More informationChapter. Quantitative assessment of white matter lesions in patients with a bilateral fetal variant of the circle of Willis.
Chapter 8 Quantitative assessment of white matter lesions in patients with a bilateral fetal variant of the circle of Willis. The SMART Study Chapter 8 Abstract Background The fetal type posterior (FTP)
More informationOriginal Paper. Cerebrovasc Dis 2017;43: DOI: /
Original Paper Received: September 4, 2016 Accepted: November 8, 2016 Published online: January 31, 2017 Do Lacunar Infarcts Have Different Aetiologies? Risk Factor Profiles of Lacunar Infarcts in Deep
More informationPrognostic Significance of Coronary Collaterals in Patients With Coronary Heart Disease Having Percutaneous Transluminal Coronary Angioplasty
Prognostic Significance of Coronary Collaterals in Patients With Coronary Heart Disease Having Percutaneous Transluminal Coronary Angioplasty Jeroen Koerselman, MD, PhD a, Peter P.T. de Jaegere, MD, PhD
More informationSupplementary Online Content
Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines
More informationPrevalence and Prognosis of Asymptomatic Vertebral Artery Origin Stenosis in Patients With Clinically Manifest Arterial Disease
Prevalence and Prognosis of Asymptomatic Vertebral Artery Origin Stenosis in Patients With Clinically Manifest Arterial Disease Annette Compter, MD; H. Bart van der Worp, MD; Ale Algra, MD; L. Jaap Kappelle,
More informationSilent Infarction in Patients with First-ever Stroke
221 Silent Infarction in Patients with First-ever Stroke Cheung-Ter Ong 1, Wen-Pin Chen 2, Sheng-Feng Sung 1, Chi-Shun Wu 1, and Yung-Chu Hsu 1 Abstract- Background / Purpose: Silent infarcts (SIs) are
More informationBrain atrophy in patients with arterial disease The SMART-MR study
Brain atrophy in patients with arterial disease The SMART-MR study Auke P.A. Appelman Brain atrophy in patients with arterial disease. The SMART-MR study Thesis, Utrecht University ISBN 978-90-393-4805-5
More informationOBJECTIVE RESEARCH DESIGN AND METHODS RESULTS CONCLUSIONS. Diabetes Care Volume 37, September EPIDEMIOLOGY/HEALTH SERVICES RESEARCH
Diabetes Care Volume 37, September 2014 2515 Metabolic Syndrome, Prediabetes, and Brain Abnormalities on MRI in Patients With Manifest Arterial Disease: The SMART-MR Study Diabetes Care 2014;37:2515 2521
More informationProgression of Cerebral Small Vessel Disease in Relation to Risk Factors and Cognitive Consequences Rotterdam Scan Study
Progression of Cerebral Small Vessel Disease in Relation to Risk Factors and Cognitive Consequences Rotterdam Scan Study Ewoud J. van Dijk, MD, PhD; Niels D. Prins, MD, PhD; Henri A. Vrooman, PhD; Albert
More informationAsymptomatic lacunar infarcts, white matter lesions, cerebral
Ambulatory Blood Pressure in Patients With Lacunar Stroke Association With Total MRI Burden of Cerebral Small Vessel Disease Pim Klarenbeek, MD; Robert J. van Oostenbrugge, MD, PhD; Rob P.W. Rouhl, MD,
More informationArterial stiffness and progression of structural brain changes The SMART-MR study
ARTICLES Arterial stiffness and progression of structural brain changes The SMART-MR study Hadassa M. Jochemsen, MD, PhD Majon Muller, MD, PhD Michiel L. Bots, MD, PhD Philip Scheltens, MD, PhD Koen L.
More informationThe Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging
The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging REBECCA F. GOTTESMAN, MD PHD ASSOCIATE PROFESSOR OF NEUROLOGY AND EPIDEMIOLOGY JOHNS HOPKINS UNIVERSITY OCTOBER 20, 2014 Outline
More informationPrior brain infarctions are commonly seen on magnetic
Prevalence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study Sarah E. Vermeer, MD; Peter J. Koudstaal, MD, PhD; Matthijs Oudkerk, MD, PhD; Albert Hofman, MD, PhD; Monique
More informationW hite matter high intensity lesions (WML) on T2
576 PAPER Significance of white matter high intensity lesions as a predictor of stroke from arteriolosclerosis H Yamauchi, H Fukuda, C Oyanagi... See end of article for authors affiliations... Correspondence
More informationWHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.
WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:
More informationReceived: 15 September 2014 /Accepted: 20 November 2014 /Published online: 6 December 2014 # Springer-Verlag Berlin Heidelberg 2014
Neuroradiology (2015) 57:269 274 DOI 10.1007/s00234-014-1472-6 DIAGNOSTIC NEURORADIOLOGY Quantification of structural cerebral abnormalities on MRI 18 months after aneurysmal subarachnoid hemorrhage in
More informationCerebellar Cortical Infarct Cavities Correlation With Risk Factors and MRI Markers of Cerebrovascular Disease
Cerebellar Cortical Infarct Cavities Correlation With Risk Factors and MRI Markers of Cerebrovascular Disease Laurens J.L. De Cocker, MD; Raoul P. Kloppenborg, MD, PhD; Yolanda van der Graaf, MD, PhD;
More informationHEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM
REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,
More informationComparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes
Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes Joshua A Salomon, Anushka Patel, Bruce Neal, Paul Glasziou, Diederick E. Grobbee,
More informationResearch Article Abdominal Aortic Aneurysms and Coronary Artery Disease in a Small Country with High Cardiovascular Burden
ISRN Cardiology, Article ID 825461, 4 pages http://dx.doi.org/10.1155/2014/825461 Research Article Abdominal Aortic Aneurysms and Coronary Artery Disease in a Small Country with High Cardiovascular Burden
More informationHow would you manage Ms. Gold
How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56
More informationThe Impact of Smoking on Acute Ischemic Stroke
Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease
More informationThere is no gold standard for the diagnosis of
1220 Original Contributions Silent Stroke in Patients With Transient Ischemic Attack or Minor Ischemic Stroke D. Herderschee, MD; A. Hijdra, MD; A. Algra, MD; P.J. Koudstaal, MD; L.J. Kappelle, MD; and
More informationSilent brain infarcts, focal ischemic lesions in the brain
Silent Brain Infarcts in Patients With Manifest Vascular Disease Janneke L.P. Giele, MsC; Theo D. Witkamp, MD; Willem P.T.M. Mali, MD, PhD; Yolanda van der Graaf, MD, PhD; for the SMART Study Group Background
More informationSilent brain infarcts are frequently seen on MRIs in healthy
Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study Sarah E. Vermeer, MD, PhD; Tom den Heijer, MD; Peter J. Koudstaal, MD, PhD; Matthijs Oudkerk, MD, PhD; Albert
More informationVague Neurological Conditions
Vague Neurological Conditions Dr. John Lefebre, MD, FRCPC Chief Regional Medical Director Europe, India, South Africa, Middle East and Turkey Canada 2014 2 3 4 Agenda Dr. John Lefebre, M.D., FRCPC 1. TIA
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/42751 holds various files of this Leiden University dissertation Author: Foster-Dingley, J.C. Title: Blood pressure in old age : exploring the relation
More informationEdinburgh Research Explorer
Edinburgh Research Explorer Stroke subtype, vascular risk factors and total MRI brain small vessel disease burden Citation for published version: Staals, J, Makin, S, Doubal, F, Dennis, M & Wardlaw, J
More informationIntroduction. Keywords: Infrainguinal bypass; Prognosis; Haemorrhage; Anticoagulants; Antiplatelets.
Eur J Vasc Endovasc Surg 30, 154 159 (2005) doi:10.1016/j.ejvs.2005.03.005, available online at http://www.sciencedirect.com on Risk of Major Haemorrhage in Patients after Infrainguinal Venous Bypass Surgery:
More informationRedgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on
6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor
More informationCADASIL: structural MR imaging changes and apolipoprotein E genotype S E V E N
CADASIL: structural MR imaging changes and apolipoprotein E genotype S E V E N CADASIL: structural MR imaging changes and apolipoprotein E genotype R. van den Boom S.A.J. Lesnik Oberstein A.A. van den
More informationPerforating arteries originating from the posterior communicating artery: a 7.0-Tesla MRI study
Eur Radiol (2009) 19: 2986 2992 DOI 10.1007/s00330-009-1485-4 MAGNETIC RESONANCE Mandy M. A. Conijn Jeroen Hendrikse Jaco J. M. Zwanenburg Taro Takahara Mirjam I. Geerlings Willem P. Th. M. Mali Peter
More informationIntroduction. Risk factors of PVD 5/8/2017
PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental
More informationAndrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION
2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL
More informationZhenyu Jia, MD,* Wasif Mohammed, MD,* Yiru Qiu, MD, Xunning Hong, MD,* and Haibin Shi, MD, PhD*
Hypertension Increases the Risk of Cerebral Microbleed in the Territory of Posterior Cerebral Artery: A Study of the Association of Microbleeds Categorized on a Basis of Vascular Territories and Cardiovascular
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the
More informationSupplementary Online Content
Supplementary Online Content Hooshmand B, Magialasche F, Kalpouzos G, et al. Association of vitamin B, folate, and sulfur amino acids with brain magnetic resonance imaging measures in older adults: a longitudinal
More informationDR as a Biomarker for Systemic Vascular Complications
DR as a Biomarker for Systemic Vascular Complications Lihteh Wu MD Asociados de Mácula, Vítreo y Retina de Costa Rica San José, Costa Rica LW65@cornell.edu Disclosures Dr Wu has received lecture fees from
More informationSilent brain infarctions and high white matter grade
Hyperintensity on Cranial Magnetic Resonance Imaging A Predictor of Stroke Lewis H. Kuller, MD, DrPH; W.T. Longstreth Jr, MD, MPH; Alice M. Arnold, PhD; Charles Bernick, MD; R. Nick Bryan, MD, PhD; Norman
More informationAortic Atherosclerosis at Middle Age Predicts Cerebral White Matter Lesions in the Elderly
Aortic Atherosclerosis at Middle Age Predicts Cerebral White Matter Lesions in the Elderly Frank-Erik de Leeuw, MD, PhD; Jan Cees de Groot, MD, PhD; Matthijs Oudkerk, MD, PhD; Jacqueline C.M. Witteman,
More informationSupplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
More informationSilent cerebral infarction predicts vascular events in hemodialysis patients
Kidney International, Vol. 67 (2005), pp. 2434 2439 Silent cerebral infarction predicts vascular events in hemodialysis patients TOSHIHIDE NAGANUMA,JUNJI UCHIDA,KENJI TSUCHIDA, YOSHIAKI TAKEMOTO, SHINJI
More informationSelecting subjects for ultrasonographic screening for aneurysms of the abdominal aorta: four different strategies
International Epidemiological Association 1999 Printed in Great Britain International Journal of Epidemiology 1999;28:682 686 Selecting subjects for ultrasonographic screening for aneurysms of the abdominal
More informationSeveral longitudinal population-based studies have suggested
Association of MRI Markers of Vascular Brain Injury With Incident Stroke, Mild Cognitive Impairment, Dementia, and Mortality The Framingham Offspring Study Stéphanie Debette, MD, PhD; Alexa Beiser, PhD;
More informationEpidemiologic and clinical comparison of renal artery stenosis in black patients and white patients
ORIGINAL ARTICLES Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients Andrew C. Novick, MD, Safwat Zald, MD, David Goldfarb, MD, and Ernest E. Hodge, MD,
More informationMORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance
MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1
More informationCerebral small vessel disease
Cerebral small vessel disease What is it? What are the clinical syndromes? How do we diagnose it? What is the pathophysiology? New insights from genetics? Possible therapies? Small Vessel disease Changes
More informationMORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance
MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1
More informationBaldness and Coronary Heart Disease Rates in Men from the Framingham Study
A BRIEF ORIGINAL CONTRIBUTION Baldness and Coronary Heart Disease Rates in Men from the Framingham Study The authors assessed the relation between the extent and progression of baldness and coronary heart
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationThrough the looking glass: Risk factors, radiological hallmarks and cognitive function in cerebral small vessel disease Kloppenborg, R.P.
UvA-DARE (Digital Academic Repository) Through the looking glass: Risk factors, radiological hallmarks and cognitive function in cerebral small vessel disease Kloppenborg, R.P. Link to publication Citation
More informationMagnetic resonance imaging, image analysis:visual scoring of white matter
Supplemental method ULSAM Magnetic resonance imaging, image analysis:visual scoring of white matter hyperintensities (WMHI) was performed by a neuroradiologist using a PACS system blinded of baseline data.
More informationMedical management of abdominal aortic aneurysms
Medical management of abdominal aortic aneurysms Definition of AAA - Generally a 50% increase in native vessel diameter - Diameter 3 cm - Relative measures compared with nondiseased aortic segments less
More informationPFO Management update
PFO Management update May 12, 2017 Peter Casterella, MD Swedish Heart and Vascular 1 PFO Update 2017: Objectives Review recently released late outcomes of RESPECT trial and subsequent FDA approval of PFO
More informationFour Tissue Segmentation in ADNI II
Four Tissue Segmentation in ADNI II Charles DeCarli, MD, Pauline Maillard, PhD, Evan Fletcher, PhD Department of Neurology and Center for Neuroscience, University of California at Davis Summary Table of
More informationClinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease
Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon
More informationPotential recommendations for CT coronary angiography in athletes
Potential recommendations for CT coronary angiography in athletes B.K. Velthuis Dept. of Radiology UMC Utrecht, the Netherlands EuroPRevent 15 April 2011 Declaration of interest Philips Medical Systems
More informationDisclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter
More informationTransient Ischemic Attacks and Risk of Stroke in an Elderly Poor Population
Transient Ischemic Attacks and Risk of Stroke in an Elderly Poor Population BY A. M. OSTFELD, M.D., R. B. SHEKELLE, Ph.D., AND H. L. KLAWANS, M.D. Abstract: Transient Ischemic A t tacks and Risk of Stroke
More informationGALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
More informationLDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC
Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive
More informationStatistical analysis plan
Statistical analysis plan Prepared and approved for the BIOMArCS 2 glucose trial by Prof. Dr. Eric Boersma Dr. Victor Umans Dr. Jan Hein Cornel Maarten de Mulder Statistical analysis plan - BIOMArCS 2
More informationchapter 7 Brain MRI correlates of impaired cognition in patients with type 2 diabetes mellitus
chapter 7 Brain MRI correlates of impaired cognition in patients with type 2 diabetes mellitus S.M.Manschot, A.M.A. Brands, J. van der Grond, R.P.C. Kessels, A. Algra, L.J. Kappelle & G.J. Biessels. Diabetes,
More informationBlood Vessels. Dr. Nabila Hamdi MD, PhD
Blood Vessels Dr. Nabila Hamdi MD, PhD ILOs Understand the structure and function of blood vessels. Discuss the different mechanisms of blood pressure regulation. Compare and contrast the following types
More informationSubclavian artery Stenting
Subclavian artery Stenting Etiology Atherosclerosis Takayasu s arteritis Fibromuscular dysplasia Giant Cell Arteritis Radiation-induced Vascular Injury Thoracic Outlet Syndrome Neurofibromatosis Incidence
More informationFILE / PERIVENTRICULAR MICROVASCULAR ISCHEMIC CHANGES EBOOK
07 June, 2018 FILE / PERIVENTRICULAR MICROVASCULAR ISCHEMIC CHANGES EBOOK Document Filetype: PDF 365.11 KB 0 FILE / PERIVENTRICULAR MICROVASCULAR ISCHEMIC CHANGES EBOOK I recently had a MRI last week with
More informationThe TNT Trial Is It Time to Shift Our Goals in Clinical
The TNT Trial Is It Time to Shift Our Goals in Clinical Angioplasty Summit Luncheon Symposium Korea Assoc Prof David Colquhoun 29 April 2005 University of Queensland, Wesley Hospital, Brisbane, Australia
More information2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.
2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature
More informationRole of imaging in risk assessment models: the example of CIMT
Role of imaging in risk assessment models: the example of CIMT Diederick E. Grobbee, MD, PhD, FESC Professor of Clinical Epidemiology Julius Center for Health Sciences and Primary Care, University Medical
More informationClinical and magnetic resonance observations in cerebral small-vessel disease Kwa, V.I.H.
UvA-DARE (Digital Academic Repository) Clinical and magnetic resonance observations in cerebral small-vessel disease Kwa, V.I.H. Link to publication Citation for published version (APA): Kwa, V. I. H.
More informationImpact of Silent Infarction on the Outcome of Stroke Patients
ORIGINAL ARTICLE Impact of Silent Infarction on the Outcome of Stroke Patients Cheung-Ter Ong, 1 * Kuo-Chun Sung, 2 Sheng-Feng Sung, 1 Chi-Shun Wu, 1 Yung-Chu Hsu, 1 Yu-Hsiang Su 1 Background/Purpose:
More informationTable 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use
Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use Baseline characteristics Users (n = 28) Non-users (n = 32) P value Age (years) 67.8 (9.4) 68.4 (8.5)
More informationFY 2011 WISEWOMAN Approved ICD-9 Code List
243 Congenital hypothyroidism 245.0 Thyroiditis; Acute thyroiditis 245.1 Thyroiditis; Subacute thyroiditis 245.2 Thyroiditis; Chronic lymphocytic thyroiditis 245.3 Thyroiditis; Chronic fibrous thyroiditis
More informationThe Burden of the Diabetic Heart
The Burden of the Diabetic Heart Dr. Ghaida Kaddaha (MBBS, MRCP-UK, FRCP-london) Diabetes Unit Rashid Hospital Dubai U.A.E Risk of CVD in Diabetes Morbidity and mortality from CVD is 2-4 fold higher than
More informationDeclaration of conflict of interest. Dominique de Kleijn is founder of a UMC Utrecht spin-off biomarker company Cavadis BV
Declaration of conflict of interest Dominique de Kleijn is founder of a UMC Utrecht spin-off biomarker company Cavadis BV BIOMARKERS OF DISEASE Microvesicle proteins as diagnostic and predictive biomarkers
More informationTable S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis
SUPPLEMENTARY MATERIAL TEXT Text S1. Multiple imputation TABLES Table S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis Table S2. List of drugs included as immunosuppressant
More informationPRESERVE: How intensively should we treat blood pressure in established cerebral small vessel disease? Guide to assessing MRI scans
PRESERVE: How intensively should we treat blood pressure in established cerebral small vessel disease? Guide to assessing MRI scans Inclusion Criteria Clinical syndrome Patients must have clinical evidence
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationSupplementary Online Content
Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic
More informationOriginal Contributions. Prospective Comparison of a Cohort With Asymptomatic Carotid Bruit and a Population-Based Cohort Without Carotid Bruit
98 Original Contributions Prospective Comparison of a Cohort With Carotid Bruit and a Population-Based Cohort Without Carotid Bruit David O. Wiebers, MD, Jack P. Whisnant, MD, Burton A. Sandok, MD, and
More informationNon-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus
Diabetologia (2011) 54:73 77 DOI 10.1007/s00125-010-1945-z SHORT COMMUNICATION Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus S. van Dieren & U. Nöthlings & Y.
More informationGeneral introduction. Chapter 1
Chapter 1 Despite a better understanding of the aetiology and pathophysiology of atherothrombotic vascular disease, and the availability of effective treatment modalities, the burden of vascular disease
More informationAutonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors
Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti
More informationTrigger factors for rupture of intracranial aneurysms in relation to patient and aneurysm characteristics
J Neurol (2012) 259:1298 1302 DOI 10.1007/s00415-011-6341-1 ORIGINAL COMMUNICATION Trigger factors for rupture of intracranial aneurysms in relation to patient and aneurysm characteristics Monique H. M.
More informationMagnetic resonance imaging (MRI) has the potential to
Frequency and Location of Microbleeds in Patients With Primary Intracerebral Hemorrhage Gudrun Roob, MD; Anita Lechner, MD; Reinhold Schmidt, MD; Erich Flooh, MSc; Hans-Peter Hartung, MD; Franz Fazekas,
More informationOrthostatic hypotension is common in elderly people 1 4
CLINICAL INVESTIGATIONS Orthostatic Hypotension and Risk of Cardiovascular Disease in Elderly People: The Rotterdam Study Germaine C. Verwoert, w Francesco U. S. Mattace-Raso, MD, PhD, w Albert Hofman,
More informationPathology of Hypertension
2016-03-07 Pathology of Hypertension Honghe Zhang honghezhang@zju.edu.cn Tel:88208199 Department of Pathology ❶ Genetic predisposition ❷ Dietary factors ❸ Environmental factors ❹ Others Definition and
More informationChapter 6. Angiotensin-converting enzyme, progression of brain atrophy, vascular brain lesions and cognition
Chapter 6 Angiotensin-converting enzyme, progression of brain atrophy, vascular brain lesions and cognition H.M. Jochemsen, M.I. Geerlings, A.M. Grool, K.L. Vincken, W.P.Th.M. Mali, Y. van der Graaf, M.
More informationComparison of Five Major Recent Endovascular Treatment Trials
Comparison of Five Major Recent Endovascular Treatment Trials Sample size 500 # sites 70 (100 planned) 316 (500 planned) 196 (833 estimated) 206 (690 planned) 16 10 22 39 4 Treatment contrasts Baseline
More information(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects
Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values
More informationLecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors
Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life
More informationHYPERTENSIVE VASCULAR DISEASE
HYPERTENSIVE VASCULAR DISEASE Cutoffs in diagnosing hypertension in clinical practice sustained diastolic pressures >90 mm Hg, or sustained systolic pressures >140 mm Hg Malignant hypertension A small
More informationThe Diabetes Link to Heart Disease
The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM
More information